Selected article for: "bronchoalveolar lavage and old woman"

Author: Barben, Jérémy; Quipourt, Valérie; Vovelle, Jérémie; Putot, Alain; Manckoundia, Patrick
Title: Not COVID-19, Don’t Overlook Pneumocystis in Patients on Gefitinib!
  • Cord-id: lndu2ix0
  • Document date: 2021_2_21
  • ID: lndu2ix0
    Snippet: SIMPLE SUMMARY: COVID-19 pneumonia can be confused with Pneumocystis jirovecii pneumonia (PJP) on computed tomography and is a source of misdiagnosis. This can lead to mistreatment and an increased risk of mortality. Gefitinib, a tyrosine kinase inhibitor anti-EGFR used in cancer therapy and corticosteroids, could increase the risk of PJP. ABSTRACT: An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomogr
    Document: SIMPLE SUMMARY: COVID-19 pneumonia can be confused with Pneumocystis jirovecii pneumonia (PJP) on computed tomography and is a source of misdiagnosis. This can lead to mistreatment and an increased risk of mortality. Gefitinib, a tyrosine kinase inhibitor anti-EGFR used in cancer therapy and corticosteroids, could increase the risk of PJP. ABSTRACT: An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia. RT-PCR for Sars-Cov-2 was twice negative. PCR for Pneumocystis jirovecii was positive on bronchoalveolar lavage. The final diagnosis was Pneumocystis jirovecii pneumonia. Therefore, physicians must be careful not to misdiagnose COVID-19, especially in cancer patients on small-molecule therapeutics like gefitinib and corticosteroids.

    Search related documents:
    Co phrase search for related documents